Science ❯ Biology ❯ Cell Biology ❯ Immunology

Cancer Immunotherapy

Tumours Secrete PRDX1 Antioxidant to Silence Cancer‑Killing T Cells

Preclinical experiments show removing the extracellular antioxidant restores T cell activation and can make resistant tumours respond to checkpoint immunotherapy.

3 ARTICLES

last yr.

UCLA Details Off-the-Shelf CAR-NKT Therapy With Preclinical Success in Metastatic Kidney Cancer

9 ARTICLES

last yr.

AI Drives Next-Generation Melanoma Immunotherapies Toward In Vivo Testing

5 ARTICLES

last yr.

Universal mRNA Vaccine Eradicates Tumors in Mice and Advances Toward Human Trials